SCHEMBL6360688

SCHEMBL6360688

O=C(Nc1ccc(Cl)cc1C(=O)O)c1cccc(C(=O)c2ccc3c(c2)OCO3)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 7/20 0.64
RAB9A P51151 7/20 0.62
NPC1 O15118 6/20 0.62
CASP3 P42574 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
AKR1C4 P17516 1/20 0.61
AKR1C3 P42330 1/20 0.61
AKR1C2 P52895 1/20 0.61
AKR1C1 Q04828 1/20 0.61
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
PTGS2 P35354 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
TP53 P04637 2/20 0.56
NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359308 0.92 SERPINE1 (0.68) SERPINE1RAB9ANPC1CASP3SENP7
SCHEMBL6351306 0.85 SERPINE1 (0.82) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6349319 0.84 SERPINE1 (0.85) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6359691 0.81 SERPINE1 (0.71) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6353650 0.80 MEN1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL420616 0.79 SERPINE1 (1.00) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6358526 0.79 SERPINE1 (0.67) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6357753 0.79 SERPINE1 (0.67) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL2274216 0.79 RAB9A (0.60) RAB9ANPC1CASP3SENP7PTGS2
SCHEMBL6349587 0.78 NPC1 (0.64) RAB9ANPC1CASP3SENP7AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885RAB9A 3062/4885NPC1 3512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.